Soft pastels · Free shipping over $75 · Shop the boutique
Login Register
glp-1 parkinson's disease

glp-1 parkinson's disease A New Treatment Strategy for through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Neuroprotective Actions of Glucagon-Like Peptide-1

SKU: 85632935068

4.0
USD25.29 USD69.29

Pay in 4 interest-free payments of $6.32 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 2 - Oct 7

Description

Mol Psychiatry 28:217229

glp-1 parkinson's disease A New Treatment Strategy for through the GutBrain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Neuroprotective Actions of Glucagon-Like Peptide-1

Furman, B

glp-1 parkinson's disease A New Treatment Strategy for through the GutBrain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Neuroprotective Actions of Glucagon-Like Peptide-1

In one study, liraglutide and semaglutide were reported to mitigate the development of plaque lesions by changing the inflammatory pathway in a mouse model of AS (124)

glp-1 parkinson's disease A New Treatment Strategy for through the GutBrain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Neuroprotective Actions of Glucagon-Like Peptide-1

Such findings underscore its therapeutic potential in inflammatory disorders like arthritis and inflammatory bowel disease

glp-1 parkinson's disease A New Treatment Strategy for through the GutBrain Axis: The Glucagon-Like Peptide-1 Receptor Pathway Neuroprotective Actions of Glucagon-Like Peptide-1
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products